Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Photoreceptors and Visual Pathways

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...

Oxidation of Phenols to Quinones

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...

Role of Reduced Coenzymes NADH and FADH₂

Role of Reduced Coenzymes NADH and FADH₂

The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Securing central venous catheters: PT fixation technique.

Annals of cardiac anaesthesia·2022

Same author

Comparative study of outcomes between locking plates and three-dimensional plates in mandibular fractures.

National journal of maxillofacial surgery·2021

Same author

Current views on Medicinal Chemistry <i>versus</i> Green Chemistry for Management of Broad-spectrum Health Issues.

Medicinal chemistry (Shariqah (United Arab Emirates))·2020

Same author

The Language Development <i>Via</i> FOXP2 in Autism Spectrum Disorder: A Review.

Current pharmaceutical design·2020

Same author

Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.

Endocrine, metabolic & immune disorders drug targets·2020

Same author

Ajmalicine and its Analogues Against AChE and BuChE for the Management of Alzheimer's Disease: An <i>In-silico</i> Study.

Current pharmaceutical design·2020

Search research articles

Related Experiment Video

Updated: Nov 18, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Coenzyme Q and its role in glaucoma.

¹Ibnsina Academy of Medieval Sciences, Aligarh, India.

Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society

|February 5, 2021

Summary

Coenzyme Q shows promise as a neuroprotectant for glaucoma, potentially offering an alternative to intra-ocular pressure (IOP) lowering treatments. Further multi-center trials are recommended to confirm its efficacy in managing glaucoma.

Keywords:

Coenzyme Q10 glaucoma mitochondria neuroprotectants retinal ganglion cells

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

Related Experiment Videos

Last Updated: Nov 18, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

Area of Science:

Ophthalmology
Neuroscience
Pharmacology

Background:

Current glaucoma management primarily focuses on lowering intra-ocular pressure (IOP).
This approach is not universally effective, driving research into non-IOP lowering therapies.
Coenzyme Q, a vitamin-like compound, has shown potential neuroprotective effects in glaucoma models.

Purpose of the Study:

To systematically review the pharmacology, physiology, metabolism, and role of Coenzyme Q in glaucoma.
To evaluate the existing evidence for Coenzyme Q's neuroprotective efficacy in glaucoma.

Main Methods:

Conducted an English-language literature search using PubMed, Google Scholar, and Scopus.
Systematically reviewed studies investigating Coenzyme Q in glaucoma models and clinical contexts.

Main Results:

All reviewed studies reported positive outcomes for Coenzyme Q as a neuroprotectant.
A significant portion of the research on Coenzyme Q in glaucoma originates from a single research group.

Conclusions:

Coenzyme Q demonstrates potential as a neuroprotective agent for glaucoma.
Further multi-center trials are essential to validate these findings and establish broader clinical impact.